Cd26/Dipeptidyl Peptidase IV in Context-Reference-Cited by-同舟云学术

Cd26/Dipeptidyl Peptidase IV in Context

Published:1999-08-02 Issue:3 Volume:190 Page:301-306
ISSN:0022-1007
Container-title:Journal of Experimental Medicine
language:en
Short-container-title:

Author:

Iwata Satoshi¹,Morimoto Chikao¹²

Affiliation:

1. From the Division of Tumor Immunology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115

2. Department of Clinical Immunology and AIDS Research Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108, Japan

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Link

http://rupress.org/jem/article-pdf/190/3/301/1122742/99-1037.pdf

Reference31 articles.

1. The structure and function of CD26 in the T-cell immune response;Morimoto;Immunol. Rev.,1998

2. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanoma cells;Wesley;J. Exp. Med.,1999

3. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase;Morrison;J. Exp. Med.,1993

4. Hematopoietic differentiation antigens that are membrane-associated enzymescutting is the key!;Shipp;Blood.,1993

5. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression;Papandreou;Nat. Med.,1998

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy;Cancers;2024-06-30

2. Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer;Physical Sciences Reviews;2023-05-11

3. Human Coronavirus Cell Receptors Provide Challenging Therapeutic Targets;Vaccines;2023-01-13

4. CD26 and Cancer;Cancers;2022-10-23

5. Design, synthesis, molecular simulation, and biological activities of novel quinazolinone-pyrimidine hybrid derivatives as dipeptidyl peptidase-4 inhibitors and anticancer agents;New Journal of Chemistry;2020